HUTCHMED (China) (HCM) Minority Interest (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Minority Interest came in at $1.7 million in Q4 2025, up 11.79% year-on-year from $1.5 million in Q4 2024, and down 86.67% on a QoQ basis from $12.9 million in Q2 2025.
HUTCHMED (China) (HCM) Minority Interest (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Minority Interest data on file, last reported at $1.7 million in Q4 2025.
- On a quarterly basis, Minority Interest rose 11.79% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $1.7 million, a 11.79% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 12.2% from the prior year.
- Minority Interest for Q4 2025 stood at $1.7 million, down from $12.9 million in the prior quarter.
- Over the last five years, Minority Interest for HCM reached as high as $1.6 billion in Q4 2023 and fell as low as $1.5 million in Q4 2024.
- Historically, Minority Interest has averaged $165.2 million across 5 years, with a median of $12.9 million in 2025.
- Across the five-year window, Minority Interest soared 48423.96% in 2023 and tumbled 99.91% in 2024, its largest moves.
- Year by year, Minority Interest stood at $6.8 million in 2021, then plunged by 49.85% to $3.4 million in 2022, then surged by 48423.96% to $1.6 billion in 2023, then tumbled by 99.91% to $1.5 million in 2024, then gained by 11.79% to $1.7 million in 2025.
- Per Business Quant data, the three most recent Minority Interest figures were $1.7 million in Q4 2025, $12.9 million in Q2 2025, and $1.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.71 Mn |
| Jun 30, 2025 | 12.86 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Jun 30, 2024 | 11.93 Mn |
| Dec 31, 2023 | 1.64 Bn |
| Jun 30, 2023 | 17.98 Mn |
| Dec 31, 2022 | 3.39 Mn |
| Jun 30, 2022 | 52.12 Mn |
| Dec 31, 2021 | 6.76 Mn |
| Jun 30, 2021 | 28.90 Mn |
| Mar 31, 2021 | 36.12 Mn |
| Jun 30, 2020 | 24.93 Mn |
| Sep 30, 2019 | 24.27 Mn |
| Jun 30, 2019 | 25.15 Mn |
| Mar 31, 2019 | 24.59 Mn |
| Dec 31, 2018 | 23.26 Mn |
| Jun 30, 2018 | 26.11 Mn |
| Dec 31, 2017 | 23.23 Mn |
| Jun 30, 2017 | 22.12 Mn |
| Dec 31, 2016 | 19.79 Mn |